Naringenin Prevents Renal Injury in Experimental Hyperuricemia Through Suppressing Xanthine Oxidase, Inflammation, Apoptotic Pathway, DNA Damage, and Activating Antioxidant System
Metabolic Syndrome and Related Disorders · 2023
DOI: 10.1089/met.2023.0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolic Syndrome and Related Disorders, 2023. Verfasst von Zehra Calis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Medical Faculty, Selcuk University, Konya, Turkey. Hauptthemen laut MEDLINE: Hyperuricemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background/Purpose: This research was performed to determine the effect of naringenin (NAR) in experimental hyperuricemia (HU) induced by potassium oxonate (PO) on uric acid levels and xanthine oxidase (XO), inflammation, apoptotic pathway, DNA damage, and antioxidant system in kidney tissue. Study Design: Wistar Albino rats were categorized into four groups: (1) Control group, (2) PO group, (3) [PO+NAR] (2 weeks) group, and (4) PO (2 weeks)+NAR (2 weeks) group.
Methods
The first group was not administered any drug. In group 2, PO was administered intraperitoneally 250 mg/kg/day for 2 weeks. In the third group, 100 mg/kg/day NAR was given intraperitoneally 1 hr after PO injection for 2 weeks. In the fourth group, PO was injected for the first 2 weeks, followed by NAR injection for the second 2 weeks. Serum uric acid levels, XO, nuclear factor-kappa B, tumor necrosis factor-alpha, interleukin-17, cytochrome c, 8-Hydroxydeoxyguanosine (8-OHdG), glutathione peroxidase (GPx), and caspase-3 levels in kidney were determined.
Results
HU increased the levels of inflammatory and apoptotic parameters, XO, and 8-OHdG levels in kidney. Administration of NAR caused a decrease in these values and an increase in GPx levels.
Conclusions
The results of the study show that NAR treatment reduces serum uric acid levels, and apoptosis, inflammation, and DNA damage; increases antioxidant activity in kidney in experimental HU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Medical Faculty, Selcuk University, Konya, Turkey.
- Department of Physiology, Faculty of Medicine, Karamanoglu Mehmetbey University, Karaman, Turkey.
ORCID-Profile: Rasim Mogulkoc
Zitieren
APA
Calis, Z., Dasdelen, D., Baltaci, A. K., & Mogulkoc, R. (2023). Naringenin Prevents Renal Injury in Experimental Hyperuricemia Through Suppressing Xanthine Oxidase, Inflammation, Apoptotic Pathway, DNA Damage, and Activating Antioxidant System. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2023.0012
Vancouver
Calis Z, Dasdelen D, Baltaci AK, Mogulkoc R. Naringenin Prevents Renal Injury in Experimental Hyperuricemia Through Suppressing Xanthine Oxidase, Inflammation, Apoptotic Pathway, DNA Damage, and Activating Antioxidant System. Metabolic Syndrome and Related Disorders. 2023. doi:10.1089/met.2023.0012
BibTeX
@article{Calis2023,
author = {Calis, Zehra and Dasdelen, Dervis and Baltaci, Abdulkerim Kasim and Mogulkoc, Rasim},
title = {Naringenin Prevents Renal Injury in Experimental Hyperuricemia Through Suppressing Xanthine Oxidase, Inflammation, Apoptotic Pathway, DNA Damage, and Activating Antioxidant System},
journal = {Metabolic Syndrome and Related Disorders},
year = {2023},
doi = {10.1089/met.2023.0012}
}
EUVIMED